Drugs Health Pharma

Daiichi Sankyo-Merck’s trial lung cancer drug meets primary goal

Daiichi Sankyo and Merck & Co., Inc. will initiate talks with global regulatory agencies after an end-stage trial of its drug for a.

Read More
Drugs Health Pharma

Merck’s experimental RSV injection lowers infections in infants 

The US-based Merck and Co.’s investigational medicine to protect infants from respiratory syncytial virus (RSV) disease has resulted in lowering infections, according to.

Read More
Drugs Health Pharma

Bayer’s menopausal drug lowers hot flashes, to seek regulatory nod

HQ Team March 19, 2024: Bayer AG, a German pharmaceutical major, will seek regulatory approval for its menopausal drug after the final trials.

Read More
Drugs Medical Pharma

Glenmark gets FDA nod for trials in US on tumour, cancer patients

Glenmark Specialty SA, a subsidiary of India’s Glenmark Pharmaceuticals, has got investigational new drug clearance from the FDA to conduct clinical trials in.

Read More
Drugs Pharma

India bolsters regulators to brace global competition

India is bolstering its regulatory bodies to global standards to become a world leader in drug discovery and innovative medical devices, a minister.

Read More
Drugs Health Medical Pharma Uncategorized

India’s Marion Biotech under drug regulator’s scanner

Drug regulators started investigating Marion Biotech after Uzbekistan alleged 18 children died in Samarkand city following the consumption of cough syrup made by.

Read More